NEUROCRINE BIOSCIENCES INC Public Float
NEUROCRINE BIOSCIENCES INC (NBIX) had Public Float of $9.52 billion as of 2025-06-30, per its 10-K filed 2026-02-11.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-02-11
- 2025-06-30: Entity Public Float $9.52B.
- 2024-06-30: Entity Public Float $10.50B.
- 2023-06-30: Entity Public Float $7.90B.
- 2022-06-30: Entity Public Float $8.10B.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $9.52B 10-K · filed 2026-02-11 |
| 2024-06-30 | $10.50B 10-K · filed 2025-02-10 |
| 2023-06-30 | $7.90B 10-K · filed 2024-02-09 |
| 2022-06-30 | $8.10B 10-K · filed 2023-02-09 |
| 2021-06-30 | $9.11B 10-K · filed 2022-02-11 |
| 2020-06-30 | $11.23B 10-K · filed 2021-02-05 |
| 2019-06-30 | $5.75B 10-K · filed 2020-02-07 |
| 2018-06-30 | $7.46B 10-K · filed 2019-02-08 |
| 2017-06-30 | $3.41B 10-K · filed 2018-02-13 |
| 2016-06-30 | $2.87B 10-K · filed 2017-02-14 |
| 2015-06-30 | $3.03B 10-K · filed 2016-02-11 |
| 2014-06-30 | $825.57M 10-K · filed 2015-02-09 |
| 2013-06-30 | $646.99M 10-K · filed 2014-02-11 |
| 2012-06-30 | $439.11M 10-K · filed 2013-02-08 |
| 2011-06-30 | $374.00M 10-K · filed 2012-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |